GH

Guardant Health Inc

179.38

Sep 18 • 3:59 PM ET -3.72 (-2.03%)

182.30

Aftermarket • 6:43 PM ET +2.92 (1.63%)

Healthcare Diagnostics & Research USA Large NASD

Peers: NTRA DGX LH ILMN IQV A MEDP ICLR VEEV RVTY

| Held by: VTI VB VBK VXF SCHA IWP ARKG IWR CGGR SCHM

Scroll to Statements

Index	-
Market Cap	24.07B
Enterprise Value	24.72B
Income	-453.44M
Sales	1.18B
Book/sh	-1.67
Cash/sh	7.85
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	2506
IPO	Oct 04, 2018

P/E	-
Forward P/E	-
PEG	-
P/S	20.35
P/B	-
P/C	22.85
P/FCF	-
EV/EBITDA	-
EV/Sales	20.89
Quick Ratio	3.71
Current Ratio	4.03
Debt/Eq	-
LT Debt/Eq	-
Option/Short	Yes / Yes

EPS (ttm)	-3.50
EPS next Y	-1.91
EPS next Q	-0.75
EPS this Y	3.47%
EPS next Y	40.29%
EPS next 5Y	70.97%
EPS past 3/5Y	19.67% -4.99%
Sales past 3/5Y	29.75% 27.92%
EPS Y/Y TTM	-4.60%
Sales Y/Y TTM	42.74%
EPS Q/Q	-12.34%
Sales Q/Q	44.33%
Earnings	Jul 30 AMC
EPS/Sales Surpr.	-18.14% 6.60%

Insider Own	4.02%
Insider Trans	-14.36%
Inst Own	100.87%
Inst Trans	-2.16%
ROA	-27.95%
ROE	-
ROIC	-31.35%
Gross Margin	65.01%
Oper. Margin	-39.70%
Profit Margin	-38.33%
SMA20	7.75%
SMA50	11.37%
SMA200	49.14%
Trades

Shs Outstand	133.61M
Shs Float	128.81M
Short Float	8.58%
Short Ratio	4.46
Short Interest	11.05M
52W High	183.51 -2.25%
52W Low	55.38 223.91%
Volatility	5.52% 5.02%
ATR (14)	8.22
RSI (14)	63.13
Beta	1.58
Rel Volume	1.24
Avg Volume	2.48M
Volume	3,080,785

Perf Week	13.98%
Perf Month	9.82%
Perf Quarter	36.12%
Perf Half Y	101.37%
Perf YTD	75.62%
Perf Year	205.07%
Perf 3Y	530.73%
Perf 5Y	35.84%
Perf 10Y	-
Recom	1.34
Target Price	199.44
Prev Close	183.10
Price	179.38
Change %	-2.03%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-09-26	Resumed	UBS	Buy	$225
Sep-08-26	Initiated	Rothschild & Co Redburn	Buy	$203
Jun-26-26	Resumed	Bernstein	Outperform	$175
Jun-12-26	Initiated	RBC Capital Mkts	Outperform	$185
Jun-05-26	Initiated	Goldman	Buy	$165
Jun-02-26	Upgrade	Evercore ISI	In-line → Outperform	$160
Jun-02-26	Resumed	Wolfe Research	Outperform	$150
Feb-20-26	Reiterated	Canaccord Genuity	Buy	$125 → $135
Feb-17-26	Initiated	Robert W. Baird	Outperform	$120
Jan-05-26	Downgrade	Evercore ISI	Outperform → In-line	$105
Dec-02-25	Resumed	Morgan Stanley	Overweight	$130
Sep-25-25	Upgrade	Wolfe Research	Peer Perform → Outperform	$75
Sep-22-25	Resumed	Wells Fargo	Overweight	$72
Apr-10-25	Initiated	Mizuho	Outperform	$55
Jan-23-25	Initiated	Barclays	Overweight	$60
Jun-28-24	Upgrade	Guggenheim	Neutral → Buy	$36
Jun-03-24	Resumed	Jefferies	Buy	$32
Apr-24-24	Resumed	Craig Hallum	Buy	$28
Dec-14-23	Initiated	Guggenheim	Neutral
Dec-13-23	Initiated	Wolfe Research	Peer Perform

Show Previous Ratings

Sep-16-26 12:45PM	Guardant Health Nears Buy Point As Sales Outlook Brightens (Investor's Business Daily)
06:31AM	Cathie Wood's ARK Invest Buys AVAV Stock Again, Trims GOOGL Stake And Sells Iridium (Stocktwits)
Sep-15-26 04:57PM	Dow Jones Futures: S&P 500, Nasdaq Break Support; How Will Bonds React To Fed Rate Hike, Outlook? (Investor's Business Daily)
Sep-14-26 04:05PM	Guardant Healths Shield Blood Test Covered by EviCore by Evernorth for Colorectal Cancer Screening (Business Wire) +6.65%
Sep-09-26 03:46PM	Guardant Health and Collaborators to Present 20 Abstracts Highlighting Portfolio of Liquid Biopsy Tests for Early Detection and Ongoing Treatment Management at 2026 World Conference on Lung Cancer (Business Wire)
02:38PM	Loading…
Sep-08-26 02:38PM	Business Insider Names Guardant Health One of America's Most Innovative Businesses (Business Wire)
02:34PM	Advanced Micro Devices Upgraded, Eli Lilly Downgraded: Updated Rankings on Top Blue-Chip Stocks (InvestorPlace)
Sep-04-26 06:10PM	Guardant Health Announces Landmark FDA Approval of Guardant360 CDx as Companion Diagnostic for AstraZenecas ETCAMAH (camizestrant) in Advanced Breast Cancer (Business Wire)
Sep-01-26 08:05AM	Guardant Healths Shield Blood Test Covered by Carelon Health Services for Colorectal Cancer Screening (Business Wire)
Aug-26-26 07:07AM	Guardant Health ordered to pay $245M in patent dispute (MedTech Dive)
Aug-25-26 07:36AM	Guardant ordered to pay $245m in DNA sequencing patent dispute (Medical Device Network)
Aug-24-26 02:44PM	Guardant Health to Appeal Federal District Court Judgment (Business Wire)
02:23PM	What Is Really Moving Tempus AI Stock Right Now? (Trefis)
09:28AM	Guardant Health Dives After Losing A Patent Dispute; Judge Orders Royalties (Investor's Business Daily)
Aug-22-26 08:04AM	Palantir, Freeport Break Out, Lead Five Stocks Near Buy Points (Investor's Business Daily)
04:05PM	Loading…
Aug-10-26 04:05PM	Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Aug-03-26 01:01AM	GH- Amid Growth Stock Struggles, Stick with this Health Care Play (MoneyShow)
Aug-01-26 11:23AM	GE Aerospace, AI Play Lead Five Stocks Near Buy Points (Investor's Business Daily)
Jul-31-26 08:30AM	Guardant Health, Inc. Q2 2026 Earnings Call Summary (Moby) +6.33%
01:03AM	Guardant Health Inc (GH) (Q2 2026) Earnings Call Highlights: Revenue Surges 44% on FDA Approval ... (GuruFocus.com)
Jul-30-26 04:59PM	Guardant Health: Q2 Earnings Snapshot (Associated Press) +5.75%
04:05PM	Guardant Health Reports Second Quarter 2026 Financial Results and Increases 2026 Revenue Guidance (Business Wire)
01:41PM	Guardant Health, Stock Of The Day, Offers Entry With Earnings Due (Investor's Business Daily)
Jul-29-26 04:05PM	Guardant Health to Participate in Upcoming Investor Conferences (Business Wire)
Jul-28-26 07:13AM	Actor and Cancer Advocate Patrick Dempsey Stars in Emotional Tribute Video From Guardant Health Memorializing Those Who Have Lost Their Lives to Colorectal Cancer (Business Wire)
Jul-27-26 11:37AM	Freenome secures FDA nod for blood-based colorectal cancer test (MedTech Dive)
Jul-16-26 08:13AM	Canadian AI Microcap Cut Hospital Drug Alerts by 94%. Now It's Entering the U.S. (TSXV: SEGN) (FinanceWire)
Jul-13-26 04:50PM	Alamar Hits A High Note On Alzheimer's Buzz (Trefis)
07:22AM	Freenome colorectal cancer test data improve on earlier results (MedTech Dive)
Jul-09-26 04:25PM	The Surprising Reason Guardant Health, A Top 3% Stock, Soared To A Five-Year High (Investor's Business Daily) +5.06%
04:24PM	Loading…
04:24PM	Cancer Blood Screen SPAC's Merger Is Delayed by Test's Results (Barrons.com)
04:05PM	Guardant Health to Report Second Quarter 2026 Financial Results on July 30, 2026 (Business Wire)
Jul-06-26 04:06PM	Planet Labs Upgraded, Royal Caribbean Downgraded: Updated Rankings on Top Blue-Chip Stocks (InvestorPlace)
Jul-02-26 06:41PM	CareDx Acquires Naveris, Extends Leadership into High-Growth Specialty Oncology (Exec Edge)
07:48AM	Guardants Shield colon cancer blood test snags UnitedHealth coverage (MedTech Dive)
Jul-01-26 06:02PM	When Multi-Cancer Blood Screens Could Finally Take Off (Barrons.com) +13.82%
02:50PM	UnitedHealth Group Now Covers Guardant Health's Shield Blood Test for Colorectal Cancer Screening (Business Wire)
01:10PM	GH Stock At Over 5-Year Highs Whats The UnitedHealth Connection? (Stocktwits)
Jun-24-26 04:40PM	Dow Jones Futures: Micron Jumps On Earnings, Lifts Memory, Chip Stocks; Fed Inflation Data Due (Investor's Business Daily)
Jun-23-26 11:10PM	Dow Jones Futures: Nasdaq Breaks Key Support; FedEx, Cerebras Tumble Late With Micron Due (Investor's Business Daily)
Jun-18-26 02:14PM	Living Longer Is Big Business. These Stocks Will Benefit. (Barrons.com)
Jun-11-26 08:05AM	Guardant Health Announces FDA Approval of Guardant360 CDx as Companion Diagnostic for Boehringer Ingelheims HERNEXEOS (Business Wire)
Jun-05-26 09:36AM	Tesla upgraded, Lululemon downgraded: Wall Street's top analyst calls (The Fly) -5.60%
Jun-04-26 03:39PM	A new blood test can help detect colon cancer, but it's not as good as the test you hate to take (MarketWatch)
12:13PM	Here's Why This Colon Cancer Testing Biotech Is A Mutual Fund Favorite (Investor's Business Daily)
May-28-26 08:05AM	Guardant Health and Collaborators to Present 38 Abstracts Highlighting Breadth and Expanded Clinical Utility of Guardant Liquid Biopsy Tests Powered by InfinityAI at 2026 ASCO Annual Meeting (Business Wire)
May-27-26 04:06PM	Guardant Health Just Broke Out On Bullish News For Its Colon Cancer-Detecting Blood Test (Investor's Business Daily) +6.39%
07:47AM	American Cancer Society Recommends Guardant Health's Shield Blood Test in Updated Colorectal Cancer Screening Guidelines (Business Wire)
May-21-26 06:00AM	Guardant wins FDA approval for updated liquid biopsy (MedTech Dive)
May-20-26 11:02AM	Guardant Health Leaps On A Major Win In Cancer Detection; Will Shares Break Out? (Investor's Business Daily) +17.09%
08:05AM	FDA Approves New Guardant360 Liquid CDx, the Largest FDA-Approved Liquid Biopsy Panel with a 100x Expanded Footprint (Business Wire)
May-18-26 04:51PM	Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
May-07-26 04:46PM	Guardant Health: Q1 Earnings Snapshot (Associated Press)
04:05PM	Guardant Health Reports First Quarter 2026 Financial Results and Increases 2026 Revenue Guidance (Business Wire)
May-06-26 09:31AM	Why The Dip In TEM Stock Is A Buying Window (Trefis)
May-04-26 08:05AM	Guardant Health Receives FDA Approval for Guardant360 CDx as a Companion Diagnostic for Arvinas and Pfizer's VEPPANU (vepdegestrant) for Patients with ER+/HER2- Advanced Breast Cancer with ESR1 Mutations (Business Wire)
Apr-30-26 08:05AM	Guardant Health Announces Multi-Year Strategic Collaboration with Nuvalent to Develop Companion Diagnostics and Support Potential Commercialization of Targeted Cancer Therapies Using the Guardant Infinity Platform (Business Wire)
Apr-29-26 04:05PM	Guardant Health to Participate in Upcoming Investor Conferences (Business Wire)
Apr-16-26 04:05PM	Guardant Health to Report First Quarter 2026 Financial Results on May 7, 2026 (Business Wire) +5.44%
Apr-08-26 11:38AM	OS Therapies Appoints Craig Eagle, MD as Strategic Advisor (TMX Newsfile)
Mar-30-26 08:05AM	Guardant Health's InfinityAI Real-World Evidence Supports Approval of ENHERTU for Previously Treated Patients with HER2-Positive Metastatic Solid Tumors in Japan (Business Wire)
08:00AM	Gamehost Enters into Definitive Agreement to Be Acquired by Pure Casino Entertainment for $13.65 per Share (TMX Newsfile)
Mar-24-26 09:15AM	Verana Health and Guardant Health Partner to Advance Precision Medicine with Real-World Data (PR Newswire)
Mar-18-26 08:53PM	Gamehost to Correct Administrative Expense Allocation in Financial Statements; No Impact on Operations or Cash Flow (TMX Newsfile)
08:05AM	Guardant Health to Present 28 Abstracts Highlighting Advances in Tumor Typing, Therapy Selection and Expanded Utility of Multiomic Tissue and Liquid Biopsy Testing at AACR 2026 (Business Wire)
Mar-16-26 08:05AM	Guardant Health Launches Shield Multi-Cancer Detection (MCD) Test in Multiple Markets in Asia with Manulife Partnership (Business Wire)
Mar-13-26 08:05AM	New Guardant Health/Harris Poll Survey Shows 92% of All Eligible Americans Believe Colorectal Cancer Blood Tests Should be Accessible and Covered Similar to Medicare (Business Wire)
Mar-10-26 08:05AM	Guardant Health's Shield Blood-based Screening Test for Colorectal Cancer Now Accessible Through National Test Ordering and Collection Network of Quest Diagnostics (Business Wire)
Mar-05-26 11:51AM	BIAF vs. GH: Which Cancer Detection Stock Is the Better Buy Now? (Zacks)
08:44AM	TEM's Diagnostics Arm Expanding Rapidly: What's Driving the Growth? (Zacks)
Mar-04-26 07:00AM	Guardant Health Launches Coast-to-Coast Screening Tour, Bringing Shield Colon Cancer Blood Test to Over 100 Communities Across America (Business Wire)
Mar-03-26 07:00AM	Actor and Cancer Advocate Patrick Dempsey Partners with Guardant Health to Raise Awareness about Colorectal Cancer Screening and Shield Blood Test, Sharing His Experience Getting Screened (Business Wire)
Mar-02-26 02:57AM	Guardant Health, Inc. (GH) Strengthens Health Technology Portfolio with MetaSight Diagnostics Acquisition (Insider Monkey)
Feb-27-26 04:05PM	Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Feb-26-26 05:00PM	Grail's Stock Dropped 50% on Friday. Investors Still Have High Hopes for the Biotech. (Barrons.com)
07:48AM	Guardant Health (GH) Gained from Better-Than-Expected Results (Insider Monkey)
Feb-23-26 06:50PM	Analyst Report: Guardant Health, Inc. (Morningstar Research) -8.42%
01:20PM	Guardant Health acquires MetaSight amid positive 2026 financial outlook (Medical Device Network)
12:00PM	Guardant Health, PacBio, Align Technology, QuidelOrtho, and Omnicell Shares Are Falling, What You Need To Know (StockStory)
12:52AM	Guardant buys MetaSight for $59M upfront to acquire blood test tech (MedTech Dive)
Feb-20-26 08:30AM	Guardant Health, Inc. Q4 2025 Earnings Call Summary (Moby)
12:02AM	Guardant Health Inc (GH) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Feb-19-26 09:10PM	Guardant Health Q4 Earnings Call Highlights (MarketBeat)
07:00PM	Compared to Estimates, Guardant Health (GH) Q4 Earnings: A Look at Key Metrics (Zacks)
06:00PM	Guardant Health (GH) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
05:02PM	Guardant Health: Q4 Earnings Snapshot (Associated Press Finance)
04:42PM	Guardant Health (NASDAQ:GH) Surprises With Q4 CY2025 Sales (StockStory)
04:05PM	Guardant Health Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook (Business Wire)
Feb-18-26 05:04PM	Walmart To Report Results, Fresh Off New Highs, A New CEO And $1 Trillion Market Cap (Investor's Business Daily)
Feb-17-26 10:08PM	Earnings To Watch: Guardant Health (GH) Reports Q4 Results Tomorrow (StockStory)
06:48PM	Analyst Report: Guardant Health, Inc. (Morningstar Research)
10:09AM	What Makes Guardant Health (GH) a Good Healthcare Holding (Insider Monkey)
08:04AM	Palo Alto Earnings Due. How Will Deal Blitz Impact Guidance? (Investor's Business Daily)
Feb-14-26 09:37AM	Boeing Holds In Buy Zone, Leads 5 Stocks To Watch In Short Trading Week (Investor's Business Daily)
Feb-13-26 08:22PM	Analyst Report: Guardant Health, Inc. (Morningstar Research)
03:38PM	IPO Stock Of The Week: Health Care Leader BrightSpring Eyes New Buy Point (Investor's Business Daily)
10:20AM	Walmart Stock, Parade Of Gold Leaders Headline Another Busy Earnings Calendar (Investor's Business Daily)
Feb-12-26 02:35PM	Guardant Health Launches Community Colorectal Cancer Screening Grant Program in Recognition of CRC Awareness Month, Applications Now Open (PR Newswire)
10:00AM	Will Guardant Health (GH) Report Negative Earnings Next Week? What You Should Know (Zacks)
09:10AM	Alnylam Pharmaceuticals (ALNY) Surpasses Q4 Earnings Estimates (Zacks)

Guardant Health, Inc. is a precision oncology company, which engages in the provision of treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in December 2011 and is headquartered in Palo Alto, CA.

Co-FounderDr. Helmy Eltoukhy Ph.D.

Co-CEO & DirectorDr. AmirAli Talasaz Ph.D.

Chief Financial OfficerMr. Michael Bell

Chief Technology OfficerDr. Darya Chudova

Chief Legal Officer & Corporate SecretaryMr. John G. Saia J.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Chudova Darya	Chief Technology Officer	Sep 15 '26	Sale	178.00	7,738	1,377,364	70,635	Sep 17 05:11 PM
Krognes Steve E.	Director	Sep 16 '26	Sale	175.74	6,674	1,172,886	7,906	Sep 17 05:10 PM
Azar Alex M II	Director	Sep 16 '26	Sale	175.00	826	144,550	825	Sep 17 05:09 PM
Tariq Musa	Director	Sep 15 '26	Option Exercise	0.00	249	0	11,565	Sep 17 05:09 PM
Tariq Musa	Director	Sep 16 '26	Sale	175.00	116	20,300	11,449	Sep 17 05:09 PM
Tariq Musa	Director	Sep 16 '26	Proposed Sale	175.00	116	20,300		Sep 16 04:03 PM
Azar Alex M II	Director	Sep 16 '26	Proposed Sale	175.00	826	144,550		Sep 16 04:02 PM
Krognes Steve E.	Director	Sep 16 '26	Proposed Sale	175.74	6,674	1,172,886		Sep 16 04:00 PM
Chudova Darya	Officer	Sep 15 '26	Proposed Sale	178.00	7,738	1,377,364		Sep 15 04:11 PM
Azar Alex M II	Director	Sep 12 '26	Option Exercise	0.00	1,651	0	1,651	Sep 14 06:12 PM
Kalia Kumud	Chief Information Officer	Sep 11 '26	Sale	158.05	4,000	632,193	39,794	Sep 14 06:11 PM
Kalia Kumud	Officer	Sep 11 '26	Proposed Sale	158.05	4,000	632,193		Sep 11 04:50 PM
Talasaz AmirAli	Co-Chief Executive Officer	Aug 21 '26	Sale	169.16	37,500	6,343,384	37,500	Aug 24 05:21 PM
MIGNONE ROBERTO	Director	Aug 21 '26	Option Exercise	0.00	264	0	10,010	Aug 24 05:20 PM
Talasaz AmirAli	Officer	Aug 21 '26	Proposed Sale	169.16	37,500	6,343,384		Aug 21 04:28 PM
Hidalgo Medina Manuel	Director	Aug 17 '26	Option Exercise	0.00	232	0	4,788	Aug 18 06:16 PM
Tariq Musa	Director	Aug 15 '26	Option Exercise	0.00	250	0	11,432	Aug 18 06:14 PM
Tariq Musa	Director	Aug 17 '26	Sale	156.45	116	18,148	11,316	Aug 18 06:14 PM
Tariq Musa	Director	Aug 17 '26	Proposed Sale	156.45	116	18,148		Aug 17 05:05 PM
Monroe Terilyn J.	Chief People Officer	Aug 12 '26	Option Exercise	22.70	46,300	1,051,164	69,279	Aug 13 07:21 PM
Monroe Terilyn J.	Chief People Officer	Aug 12 '26	Sale	165.12	46,300	7,645,218	22,979	Aug 13 07:21 PM
Monroe Terilyn J.	Officer	Aug 12 '26	Proposed Sale	165.12	46,300	7,645,219		Aug 12 04:22 PM
Freeman Chris	Chief Commercial Officer	Aug 10 '26	Option Exercise	74.09	63,605	4,712,507	128,979	Aug 11 06:22 PM
Freeman Chris	Chief Commercial Officer	Aug 10 '26	Sale	169.58	63,605	10,786,111	65,374	Aug 11 06:22 PM
Freeman Chris	Officer	Aug 10 '26	Proposed Sale	169.58	63,605	10,786,111		Aug 10 05:11 PM
Hidalgo Medina Manuel	Director	Aug 05 '26	Option Exercise	32.55	950	30,922	6,256	Aug 06 05:06 PM
Hidalgo Medina Manuel	Director	Aug 05 '26	Sale	164.24	1,700	279,202	4,556	Aug 06 05:06 PM
CLARK IAN T	Director	Aug 04 '26	Option Exercise	60.63	9,088	550,998	17,155	Aug 05 05:05 PM
CLARK IAN T	Director	Aug 04 '26	Sale	158.92	14,180	2,253,451	2,975	Aug 05 05:05 PM
Hidalgo Medina Manuel	Director	Aug 05 '26	Proposed Sale	164.24	1,700	279,202		Aug 05 04:23 PM
Joyce Meghan V.	Former Affiliate	Aug 05 '26	Proposed Sale	161.29	11,183	1,803,685		Aug 05 04:21 PM
CLARK IAN T	Director	Aug 04 '26	Proposed Sale	158.92	14,180	2,253,450		Aug 04 05:09 PM
MIGNONE ROBERTO	Director	Jul 21 '26	Option Exercise	0.00	264	0	9,746	Jul 22 05:15 PM
Hidalgo Medina Manuel	Director	Jul 17 '26	Option Exercise	0.00	232	0	5,306	Jul 20 05:07 PM
Tariq Musa	Director	Jul 15 '26	Option Exercise	0.00	250	0	11,298	Jul 16 04:56 PM
Tariq Musa	Director	Jul 16 '26	Sale	163.29	116	18,942	11,182	Jul 16 04:56 PM
Tariq Musa	Director	Jul 16 '26	Proposed Sale	163.29	116	18,942		Jul 16 04:02 PM
Saia John G.	Chief Legal Officer	Jul 01 '26	Option Exercise	0.00	7,063	0	43,498	Jul 02 06:13 PM
Monroe Terilyn J.	Chief People Officer	Jul 01 '26	Option Exercise	0.00	4,020	0	25,078	Jul 02 06:12 PM
Kalia Kumud	Chief Information Officer	Jul 01 '26	Option Exercise	0.00	6,046	0	46,860	Jul 02 06:12 PM
Freeman Chris	Chief Commercial Officer	Jul 01 '26	Option Exercise	0.00	7,414	0	68,515	Jul 02 06:11 PM
Chudova Darya	Chief Technology Officer	Jul 01 '26	Option Exercise	0.00	8,030	0	82,691	Jul 02 06:10 PM
Bell Michael Brian	Chief Financial Officer	Jul 01 '26	Option Exercise	0.00	7,278	0	55,730	Jul 02 06:10 PM
Eltoukhy Helmy	Co-Chief Executive Officer	Jun 30 '26	Option Exercise	0.00	2,817	0	2,015,736	Jul 02 06:09 PM
Eltoukhy Helmy	Co-Chief Executive Officer	Jul 01 '26	Option Exercise	0.00	33,712	0	2,048,020	Jul 02 06:09 PM
Talasaz AmirAli	Co-Chief Executive Officer	Jun 30 '26	Option Exercise	0.00	2,817	0	1,884,153	Jul 02 06:09 PM
Talasaz AmirAli	Co-Chief Executive Officer	Jul 01 '26	Option Exercise	0.00	33,712	0	1,916,437	Jul 02 06:09 PM
Krognes Steve E.	Director	Jun 30 '26	Option Exercise	0.00	155	0	14,580	Jul 02 06:07 PM
Joyce Meghan V.	Director	Jul 01 '26	Proposed Sale	165.00	4,000	660,000		Jul 01 04:32 PM
Kalia Kumud	Chief Information Officer	Jun 15 '26	Buy	130.76	600	78,456	41,414	Jun 30 05:40 PM
Kalia Kumud	Chief Information Officer	Jun 15 '26	Sale	131.08	600	78,648	40,814	Jun 30 05:40 PM
Kalia Kumud	Chief Information Officer	Jun 10 '26	Sale	130.86	600	78,516	40,814	Jun 30 05:40 PM
Talasaz AmirAli	Co-Chief Executive Officer	Jun 29 '26	Option Exercise	4.18	143,028	597,857	2,024,364	Jun 30 05:13 PM
Talasaz AmirAli	Co-Chief Executive Officer	Jun 26 '26	Option Exercise	4.18	111,804	467,341	1,998,308	Jun 30 05:13 PM
Talasaz AmirAli	Co-Chief Executive Officer	Jun 29 '26	Sale	151.54	143,028	21,674,187	1,881,336	Jun 30 05:13 PM
Talasaz AmirAli	Co-Chief Executive Officer	Jun 26 '26	Sale	150.79	116,972	17,638,467	1,881,336	Jun 30 05:13 PM
Talasaz AmirAli	Officer	Jun 26 '26	Proposed Sale	150.79	260,000	39,205,972		Jun 26 05:00 PM
Joyce Meghan V.	Director	Jun 26 '26	Proposed Sale	150.04	2,000	300,082		Jun 26 04:04 PM
Joyce Meghan V.	Director	Jun 24 '26	Proposed Sale	140.02	2,000	280,045		Jun 24 04:02 PM
Tariq Musa	Director	Jun 22 '26	Sale	131.16	1,951	255,893	11,048	Jun 23 05:29 PM
POTTER MYRTLE S	Director	Jun 22 '26	Sale	131.16	1,556	204,085	20,971	Jun 23 05:28 PM
MIGNONE ROBERTO	Director	May 21 '26	Option Exercise	0.00	264	0	9,218	Jun 23 05:28 PM
MIGNONE ROBERTO	Director	Jun 21 '26	Option Exercise	0.00	264	0	9,482	Jun 23 05:28 PM
Tariq Musa	Director	Jun 17 '26	Option Exercise	0.00	4,203	0	12,999	Jun 22 05:55 PM
POTTER MYRTLE S	Director	Jun 17 '26	Option Exercise	0.00	4,203	0	22,527	Jun 22 05:54 PM
MIGNONE ROBERTO	Director	Jun 17 '26	Option Exercise	0.00	4,203	0	8,954	Jun 22 05:54 PM
Krognes Steve E.	Director	Jun 17 '26	Option Exercise	0.00	4,203	0	14,425	Jun 22 05:53 PM
Joyce Meghan V.	Director	Jun 17 '26	Option Exercise	0.00	4,203	0	15,386	Jun 22 05:53 PM
Hidalgo Medina Manuel	Director	Jun 17 '26	Option Exercise	0.00	4,435	0	5,074	Jun 22 05:52 PM
Gadde Vijaya	Director	Jun 17 '26	Option Exercise	0.00	4,203	0	28,517	Jun 22 05:51 PM
CLARK IAN T	Director	Jun 17 '26	Option Exercise	0.00	5,092	0	8,067	Jun 22 05:51 PM
POTTER MYRTLE S	Director	Jun 22 '26	Proposed Sale	131.16	1,556	204,085		Jun 22 04:09 PM
Tariq Musa	Director	Jun 22 '26	Proposed Sale	131.16	1,951	255,893		Jun 22 04:08 PM
Joyce Meghan V.	Director	Jun 22 '26	Proposed Sale	131.00	6,203	812,604		Jun 22 04:06 PM
Kalia Kumud	Chief Information Officer	Jun 15 '26	Option Exercise	0.00	638	0	41,728	Jun 17 06:07 PM
Tariq Musa	Director	Jun 15 '26	Option Exercise	0.00	250	0	8,912	Jun 16 04:37 PM
Tariq Musa	Director	Jun 16 '26	Sale	130.19	116	15,102	8,796	Jun 16 04:37 PM
Saia John G.	Chief Legal Officer	Jun 15 '26	Option Exercise	0.00	1,020	0	36,970	Jun 16 04:37 PM
Freeman Chris	Chief Commercial Officer	Jun 15 '26	Option Exercise	0.00	1,402	0	61,695	Jun 16 04:37 PM
Bell Michael Brian	Chief Financial Officer	Jun 15 '26	Option Exercise	0.00	2,039	0	49,548	Jun 16 04:36 PM
Tariq Musa	Director	Jun 16 '26	Proposed Sale	130.19	116	15,102		Jun 16 04:02 PM
Kalia Kumud	Chief Information Officer	Jun 11 '26	Sale	130.24	3,418	445,156	41,090	Jun 15 06:09 PM
Kalia Kumud	Officer	Jun 11 '26	Proposed Sale	130.24	3,418	445,156		Jun 15 04:17 PM
Kalia Kumud	Policy-Making Officer	Jun 12 '26	Proposed Sale	131.24	600	78,744		Jun 15 02:52 PM
Kalia Kumud	Chief Information Officer	Jun 10 '26	Sale	130.41	5,000	652,030	44,508	Jun 12 04:27 PM
Kalia Kumud	Officer	Jun 10 '26	Proposed Sale	130.41	5,000	652,030		Jun 10 04:04 PM
Eltoukhy Helmy	Co-Chief Executive Officer	Jun 05 '26	Sale	126.30	100,000	12,629,969	2,012,919	Jun 08 06:29 PM
Bell Michael Brian	Chief Financial Officer	Jun 05 '26	Sale	128.62	2,000	257,241	47,509	Jun 08 06:28 PM
Krognes Steve E.	Director	Jun 04 '26	Sale	132.51	9,294	1,231,522	10,222	Jun 05 07:50 PM
Eltoukhy Helmy	Officer	Jun 05 '26	Proposed Sale	126.30	100,000	12,629,970		Jun 05 04:38 PM
Bell Michael Brian	Officer	Jun 05 '26	Proposed Sale	128.62	2,000	257,241		Jun 05 04:02 PM
Joyce Meghan V.	Director	Jun 03 '26	Option Exercise	38.05	10,000	380,547	21,183	Jun 04 06:07 PM
Joyce Meghan V.	Director	Jun 03 '26	Sale	126.98	10,000	1,269,809	11,183	Jun 04 06:07 PM
Krognes Steve E.	Director	Jun 04 '26	Proposed Sale	132.51	9,294	1,231,522		Jun 04 04:10 PM
Joyce Meghan V.	Director	Jun 03 '26	Proposed Sale	126.98	10,000	1,269,809		Jun 03 04:06 PM
Krognes Steve E.	Director	May 31 '26	Option Exercise	0.00	154	0	19,516	Jun 01 05:30 PM
Hidalgo Medina Manuel	Director	May 28 '26	Sale	130.06	1,000	130,060	639	May 29 05:30 PM
Saia John G.	Chief Legal Officer	May 27 '26	Sale	125.08	10,000	1,250,836	35,950	May 28 06:32 PM
Hidalgo Medina Manuel	Director	May 28 '26	Proposed Sale	130.06	1,000	130,060		May 28 04:01 PM
Freeman Chris	Chief Commercial Officer	May 22 '26	Option Exercise	32.86	24,406	801,981	84,440	May 26 05:38 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GH

Guardant Health Inc

Upgrade your Finviz experience